schizandrin b has been researched along with Hypoxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bu, R; Chen, Y; Fan, Y; Gao, Y; Jia, J; Li, G; Liu, L; Wu, J; Yan, D; Yang, F; Zhang, S | 1 |
1 other study(ies) available for schizandrin b and Hypoxia
Article | Year |
---|---|
Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cells, Cultured; Cyclooctanes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Hypertension, Pulmonary; Hypoxia; Immunochemistry; Lignans; Medicine, Chinese Traditional; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Polycyclic Compounds; Pulmonary Artery; Schisandra; Signal Transduction; Transforming Growth Factor beta1; Up-Regulation; Vascular Remodeling | 2017 |